Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte membrane transport physiology

C Brugnara1

  • 1Department of Laboratory Medicine, Children's Hospital, Boston, MA 02115, USA.

Current Opinion in Hematology
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated cell counts on CSF samples: A multicenter performance evaluation of the GloCyte system.

International journal of laboratory hematology·2017
Same author

Clinical Applications of Automated Reticulocyte Indices.

Hematology (Amsterdam, Netherlands)·2016
Same author

Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states.

Clinical and laboratory haematology·2006
Same author

Novel therapies for prevention of erythrocyte dehydration in sickle cell anemia.

Drug news & perspectives·2003
Same author

Prevention of red cell dehydration: a possible new treatment for sickle cell disease.

Pediatric pathology & molecular medicine·2003
Same author

Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.

Blood·2001
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Targeting erythrocyte transport pathways, like K-Cl cotransport and the Gardos channel, offers therapeutic potential for sickle cell disease. Research also reveals roles for Na-H exchange in hypertension and diabetes.

Area of Science:

  • Physiology
  • Molecular Biology
  • Hematology

Background:

  • Cell volume and ion content regulation in human erythrocytes involves multiple transport pathways.
  • K-Cl cotransport and the Ca-gated K channel (Gardos channel) are crucial for sickle erythrocyte dehydration.
  • Erythrocyte Na-H (Na-Li) exchanger activity is influenced by insulin and blood pressure.

Purpose of the Study:

  • To investigate the role of erythrocyte transport pathways in cell volume regulation and disease states.
  • To evaluate therapeutic strategies targeting K-Cl cotransport and the Gardos channel in sickle cell disease.
  • To elucidate the function of the Na-H exchanger and band 3 protein in erythrocyte physiology.

Main Methods:

  • Testing therapeutic blockade of K-Cl cotransport (Mg pidolate) and Gardos channel (clotrimazole) in sickle cell models.

Related Experiment Videos

  • Investigating the influence of insulin and blood pressure on erythrocyte Na-H exchanger activity.
  • Employing targeted mutagenesis of the band 3 protein in mice.

    • Main Results:

    • Specific blockade of K-Cl cotransport and Gardos channel shows therapeutic promise for sickle cell disease.
    • Erythrocyte Na-H exchange abnormalities are linked to diabetic nephropathy and essential hypertension.
    • Absence of band 3 protein leads to hemolytic anemia and reduced erythrocyte mechanical stability.

    Conclusions:

    • Erythrocyte transport pathways are key targets for treating sickle cell disease, hypertension, and diabetes.
    • Understanding these transporters is vital for diagnosing and managing related pathologies.
    • Molecular identification of erythrocyte transporters will advance future research in normal and abnormal erythrocytes.